DrugDashboards

Docetaxel anhydrous

Docetaxel anhydrous · DOCETAXEL ANHYDROUS 10 mg/mL · Injection, Solution · Intravenous · Meitheal Pharmaceuticals Inc

NDC 71288-0144-08 · 1 VIAL, MULTI-DOSE in 1 CARTON / 8 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$160.00
Reported to Texas DSHS · 2026 annual filing · Meitheal Pharmaceuticals, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.512
HCPCS J9232 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$14,206
248 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA209634
TE code
AP
Approval date
Aug 24, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Docetaxel anhydrous (Injection, Solution)

LabelerStrengthFirst seenLast seen
Mylan Institutional LLCDOCETAXEL ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals IncDOCETAXEL ANHYDROUS 10 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDOCETAXEL ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DOCETAXEL ANHYDROUS 10 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Docetaxel anhydrous — NDC 71288-0144-08," retrieved September 3, 2026, https://drugdashboards.com/drug/71288014408.

Free to cite with attribution — see how the data is put together.